Related Experiment Video
Updated: Jul 4, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis
Anja Böhm1, Harald Staiger, Anita M Hennige
1Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, University Hospital Tübingen, D-72076 Tübingen, Germany.
Abstract:
Insulin detemir (DET) represents a myristic acid (MA)-coupled insulin derivative with protracted action due to reversible albumin binding. As compared to human insulin (HI), DET provokes no or only minor body weight gain in vivo. Therefore, we compared DET's and HI's adipogenic effects. 3T3-L1 preadipocytes were differentiated with 5 nmol/l HI, 5 nmol/l DET (=DET(equimolar)), or 20 nmol/l DET (=DET(equipotent); equipotent in terms of the reported metabolic potency in vitro). Due to differentiation-suppressive effects, albumin was excluded from the studies. During the induction period, only HI allowed clonal expansion. Moreover, HI induced a 200-fold increase in specific glycerol-3-phosphate dehydrogenase activity, whereas DET(equimolar) and DET(equipotent) were markedly less adipogenic (P=0.0033). MA did not reveal adipogenic properties, and MA pretreatment did not affect HI- or DET(equipotent)-induced adipogenesis. These results were closely reflected at the level of marker gene expression (PPARgamma2, leptin) and morphology (Oil Red O-stained intracellular lipids). We conclude that DET displays reduced adipogenity, and this could contribute to DET's weight-sparing effect in vivo.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
